These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12574149)

  • 21. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages.
    Dove DE; Su YR; Zhang W; Jerome WG; Swift LL; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):128-34. PubMed ID: 15499044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator.
    Xu S; Zhu BT; Turan V; Rusyn I; Thurman R; Peters JM; Gonzalez FJ; Conney AH
    Endocrinology; 2001 Aug; 142(8):3554-7. PubMed ID: 11459802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.
    Chinetti G; Lestavel S; Bocher V; Remaley AT; Neve B; Torra IP; Teissier E; Minnich A; Jaye M; Duverger N; Brewer HB; Fruchart JC; Clavey V; Staels B
    Nat Med; 2001 Jan; 7(1):53-8. PubMed ID: 11135616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation.
    Rowe AH; Argmann CA; Edwards JY; Sawyez CG; Morand OH; Hegele RA; Huff MW
    Circ Res; 2003 Oct; 93(8):717-25. PubMed ID: 14512442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Suchanek KM; May FJ; Robinson JA; Lee WJ; Holman NA; Monteith GR; Roberts-Thomson SJ
    Mol Carcinog; 2002 Aug; 34(4):165-71. PubMed ID: 12203367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha.
    Gazouli M; Yao ZX; Boujrad N; Corton JC; Culty M; Papadopoulos V
    Endocrinology; 2002 Jul; 143(7):2571-83. PubMed ID: 12072389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages.
    Neve BP; Corseaux D; Chinetti G; Zawadzki C; Fruchart JC; Duriez P; Staels B; Jude B
    Circulation; 2001 Jan; 103(2):207-12. PubMed ID: 11208678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway.
    Louet JF; Chatelain F; Decaux JF; Park EA; Kohl C; Pineau T; Girard J; Pegorier JP
    Biochem J; 2001 Feb; 354(Pt 1):189-97. PubMed ID: 11171094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.
    Hill MR; Clarke S; Rodgers K; Thornhill B; Peters JM; Gonzalez FJ; Gimble JM
    Infect Immun; 1999 Jul; 67(7):3488-93. PubMed ID: 10377130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation.
    Hirakata M; Tozawa R; Imura Y; Sugiyama Y
    Biochem Biophys Res Commun; 2004 Oct; 323(3):782-8. PubMed ID: 15381068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function.
    Chinetti G; Fruchart JC; Staels B
    Curr Opin Lipidol; 2003 Oct; 14(5):459-68. PubMed ID: 14501584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR.
    Chinetti G; Zawadski C; Fruchart JC; Staels B
    Biochem Biophys Res Commun; 2004 Jan; 314(1):151-8. PubMed ID: 14715259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PPARĪ³ signal transduction pathway in the foam cell formation induced by visfatin].
    Kang J; Cheng B; Jiang L
    Sheng Li Xue Bao; 2010 Oct; 62(5):427-32. PubMed ID: 20945045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: evaluation of E5324, an acyl-CoA cholesterol acyltransferase inhibitor.
    Nicholson AC; Pomerantz KB; Fujimori T; Hajjar DP
    Lipids; 1995 Aug; 30(8):771-4. PubMed ID: 7475994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent.
    Skiba PJ; Zha X; Maxfield FR; Schissel SL; Tabas I
    J Biol Chem; 1996 Jun; 271(23):13392-400. PubMed ID: 8662777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression.
    Sartippour MR; Renier G
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):104-10. PubMed ID: 10634806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
    Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
    Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins.
    Argmann CA; Sawyez CG; McNeil CJ; Hegele RA; Huff MW
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):475-82. PubMed ID: 12615696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of lipoxygenase products into cholesteryl esters by acyl-CoA:cholesterol acyltransferase in cholesterol-rich macrophages.
    Mathur SN; Albright E; Field FJ
    Biochem J; 1988 Dec; 256(3):807-14. PubMed ID: 3223954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.